CMP: 182

Unichem Laboratories Limited manufactures pharmaceutical drug formulations, bulk drugs and veterinary products. The Company's pharmaceutical products include anti-infectives, pain killers, cardiology drugs, psychiatry drugs, hormone supplements, gastro-intestinal drugs, diabetes drugs and nutritional products.

Unichem Labs is a decent bet in mid-cap pharma space trading at a P/E of 18 with dividend yields of nearly 2% in the last 12 months. It runs at a debt of 48 Crores with 14 Crores cash in hand. Revenues have risen from 657 Crores to 997 Crores in the last 5 years. Profits have been around 120 Crores in the last 5 years. Its not a growth pick, but a decent pick.